High levels of IL-17 receptors and IL-17 positive T-cells have been identified in the synovial fluid of these patients
A statistically significant increase in GLP1-R activation was observed using 1 M of either semaglutide or exendin-4 compared to untreated cells ( p 0.0001 (**** or ####) between different conditions: * used to compare with control group (no treatment) and # used to show the impact of the treatment
STEP-1: Semaglutide 2,4 mg, the standard since 2021 The STEP-1 trial (Wilding et al., NEJM 2021, PMID 33567185) randomized 1,961 overweight or obese adults (BMI 30 or BMI 27 with comorbidities) without diabetes to semaglutide 2,4 mg/week or placebo, with lifestyle interventions administered concurrently in both arms
Inconsistent Use For GLP-1 drugs to be effective, they need to be taken consistently
By activating telomerase, epithalon can reduce the shortening of telomeres, theoretically helping you age backward. I personally use the Khavinson Protocol for dosing epithalon (yes, the very same aforementioned professor), which uses the exact dosage from a fifteen-year longevity study in humans that produced impressive results for controlling telomere shortening
Conventional anticoagulants interfere with the coagulation cascade and tend to disable the bodys ability to form clots as well as thin the blood